SEARCH

SEARCH BY CITATION

References

  • BALDO, B.A., DANIEL, R.A., BERRIDGE, C.W. & KELLEY, A.E. (2003). Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol., 464, 220237.
  • BECHTHOLT, A.J. & CUNNINGHAM, C.L. (2005). Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav. Neurosci., 119, 213223.
  • BORGLAND, S.L., TAHA, S.A., SARTI, F., FIELDS, H.L. & BONCI, A. (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron, 49, 589601.
  • BOURGIN, P., HUITRON-RESENDIZ, S., SPIER, A.D., FABRE, V., MORTE, B., CRIADO, J.R., SUTCLIFFE, J.G., HENRIKSEN, S.J. & DE LECEA, L. (2000). Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci., 20, 77607765.
  • BOUTREL, B., KENNY, P.J., SPECIO, S.E., MARTIN-FARDON, R., MARKOU, A., KOOB, G.F. & DE LECEA, L. (2005). Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U.S.A., 102, 1916819173.
  • CHEMELLI, R.M., WILLIE, J.T., SINTON, C.M., ELMQUIST, J.K., SCAMMELL, T., LEE, C., RICHARDSON, J.A., WILLIAMS, S.C., XIONG, Y., KISANUKI, Y., FITCH, T.E., NAKAZATO, M., HAMMER, R.E., SAPER, C.B. & YANAGISAWA, M. (1999). Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 98, 437451.
  • COWEN, M.S., ADAMS, C., KRAEHENBUEHL, T., VENGELIENE, V. & LAWRENCE, A.J. (2005a). The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addict. Biol., 10, 233242.
  • COWEN, M.S., CHEN, F. & LAWRENCE, A.J. (2004). Neuropeptides: implications for alcoholism. J. Neurochem., 89, 273285.
  • COWEN, M.S., DJOUMA, E. & LAWRENCE, A.J. (2005b). The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. J. Pharmacol. Exp. Ther., 315, 590600.
  • COWEN, M.S. & LAWRENCE, A.J. (1999). The role of opioid–dopamine interactions in the induction and maintenance of ethanol consumption. Prog. Neuropsychopharmacol. Biol. Psychiatry, 23, 11711212.
  • COWEN, M.S. & LAWRENCE, A.J. (2001). Alterations in central preproenkephalin mRNA expression after chronic free-choice ethanol consumption by fawn-hooded rats. Alcohol. Clin. Exp. Res., 25, 11261133.
  • DE LECEA, L., KILDUFF, T.S., PEYRON, C., GAO, X., FOYE, P.E., DANIELSON, P.E., FUKUHARA, C., BATTENBERG, E.L., GAUTVIK, V.T., BARTLETT II, F.S., FRANKEL, W.N., VAN DEN POL, A.N., BLOOM, F.E., GAUTVIK, K.M. & SUTCLIFFE, J.G. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A., 95, 322327.
  • FADEL, J. & DEUTCH, A.Y. (2002). Anatomical substrates of orexin–dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience, 111, 379387.
  • FORD, G.K., AL-BARAZANJI, K.A., WILSON, S., JONES, D.N., HARBUZ, M.S. & JESSOP, D.S. (2005). Orexin expression and function: glucocorticoid manipulation, stress, and feeding studies. Endocrinology, 146, 37243731.
  • GEARY, N., WOLFE, A., POLIDORI, C., POLICANI, F. & MASSI, M. (2004). Exogeneous and endogenous CCK inhibit ethanol ingestion in Sardinian alcohol-preferring rats. Peptides, 25, 11851194.
  • GILPIN, N.W., STEWART, R.B., MURPHY, J.M. & BADIA-ELDER, N.E. (2005). Sensitized effects of neuropeptide Y on multiple ingestive behaviors in P rats following ethanol abstinence. Pharmacol. Biochem. Behav., 81, 740749.
  • GILPIN, N.W., STEWART, R.B., MURPHY, J.M., LI, T.K. & BADIA-ELDER, N.E. (2003). Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence. Alcohol. Clin. Exp. Res., 27, 787794.
  • HAGAN, J.J., LESLIE, R.A., PATEL, S., EVANS, M.L., WATTAM, T.A., HOLMES, S., BENHAM, C.D., TAYLOR, S.G., ROUTLEDGE, C., HEMMATI, P., MUNTON, R.P., ASHMEADE, T.E., SHAH, A.S., HATCHER, J.P., HATCHER, P.D., JONES, D.N., SMITH, M.I., PIPER, D.C., HUNTER, A.J., PORTER, R.A. & UPTON, N. (1999). Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A., 96, 1091110916.
  • HARA, J., BEUCKMANN, C.T., NAMBU, T., WILLIE, J.T., CHEMELLI, R.M., SINTON, C.M., SUGIYAMA, F., YAGAMI, K., GOTO, K., YANAGISAWA, M. & SAKURAI, T. (2001). Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron, 30, 345354.
  • HARRIS, G.C., WIMMER, M. & ASTON-JONES, G. (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 437, 556559.
  • HORVATH, T.L., DIANO, S. & VAN DEN POL, A.N. (1999a). Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci., 19, 10721087.
  • HORVATH, T.L., PEYRON, C., DIANO, S., IVANOV, A., ASTON-JONES, G., KILDUFF, T.S. & VAN DEN POL, A.N. (1999b). Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol., 415, 145159.
  • ISHII, Y., BLUNDELL, J.E., HALFORD, J.C., UPTON, N., PORTER, R., JOHNS, A. & RODGERS, R.J. (2005). Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behav. Brain. Res., 160, 1124.
  • IVANOV, A. & ASTON-JONES, G. (2000). Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport, 11, 17551758.
  • JASZBERENYI, M., BUJDOSO, E., KISS, E., PATAKI, I. & TELEGDY, G. (2002). The role of NPY in the mediation of orexin-induced hypothermia. Regul. Pept., 104, 5559.
  • KELLEY, A.E., BALDO, B.A., PRATT, W.E. & WILL, M.J. (2005). Corticostriatal–hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol. Behav., 86, 773795.
  • KOROTKOVA, T.M., SERGEEVA, O.A., ERIKSSON, K.S., HAAS, H.L. & BROWN, R.E. (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci., 23, 711.
  • KULKOSKY, P.J., CLAYBORNE, Y.J. & SANDOVAL, S.L. (1993). Cholecystokinin and bombesin inhibit ethanol and food intake in rats selectively bred for ethanol sensitivity. Alcohol. Clin. Exp. Res., 17, 545551.
  • LAWRENCE, A.J., KRSTEW, E. & JARROTT, B. (1996). Actions of nitric oxide and expression of the mRNA encoding nitric oxide synthase in rat vagal afferent neurons. Eur. J. Pharmacol., 315, 127133.
  • LIANG, J.H., CHEN, F., KRSTEW, E., COWEN, M.S., CARROLL, F.Y., CRAWFORD, D., BEART, P.M. & LAWRENCE, A.J. (2006). The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology, 50, 632639.
  • LIN, L., FARACO, J., LI, R., KADOTANI, H., ROGERS, W., LIN, X., QIU, X., DE JONG, P.J., NISHINO, S. & MIGNOT, E. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98, 365376.
  • LIU, X. & WEISS, F. (2002). Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci., 22, 78567861.
  • LODGE, D.J. & LAWRENCE, A.J. (2001). Comparative analysis of the central CCK system in fawn hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand. Regul. Pept., 99, 191201.
  • LODGE, D.J. & LAWRENCE, A.J. (2003). The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience, 117, 243247.
  • MILEYKOVSKIY, B.Y., KIYASHCHENKO, L.I. & SIEGEL, J.M. (2005). Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron, 46, 787798.
  • NARITA, M., NAGUMO, Y., HASHIMOTO, S., KHOTIB, J., MIYATAKE, M., SAKURAI, T., YANAGISAWA, M., NAKAMACHI, T., SHIODA, S. & SUZUKI, T. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci., 26, 398405.
  • National Institute on Alcohol Abuse and Alcoholism (2004). Alcoholism: Getting the Facts. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services.
  • NAVEILHAN, P., HASSANI, H., CANALS, J.M., EKSTRAND, A.J., LAREFALK, A., CHHAJLANI, V., ARENAS, E., GEDDA, K., SVENSSON, L., THOREN, P. & ERNFORS, P. (1999). Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med., 5, 11881193.
  • O'MALLEY, S.S., JAFFE, A.J., CHANG, G., SCHOTTENFELD, R.S., MEYER, R.E. & ROUNSAVILLE, B. (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry, 49, 881887.
  • PANDEY, S.C., CARR, L.G., HEILIG, M., ILVESKOSKI, E. & THIELE, T.E. (2003). Neuropeptide Y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol. Clin. Exp. Res., 27, 149154.
  • PANEDA, C., WINSKY-SOMMERER, R., BOUTREL, B. & DE LECEA, L. (2005). The corticotropin-releasing factor–hypocretin connection: implications in stress response and addiction. Drug News Perspect., 18, 250255.
  • PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
  • PEYRON, C., TIGHE, D.K., VAN DEN POL, A.N., DE LECEA, L., HELLER, H.C., SUTCLIFFE, J.G. & KILDUFF, T.S. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci., 18, 999610015.
  • RODGERS, R.J., HALFORD, J.C., NUNES DE SOUZA, R.L., CANTO DE SOUZA, A.L., PIPER, D.C., ARCH, J.R., UPTON, N., PORTER, R.A., JOHNS, A. & BLUNDELL, J.E. (2001). SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci., 13, 14441452.
  • SAKURAI, T., AMEMIYA, A., ISHII, M., MATSUZAKI, I., CHEMELLI, R.M., TANAKA, H., WILLIAMS, S.C., RICHARDSON, J.A., KOZLOWSKI, G.P., WILSON, S., ARCH, J.R., BUCKINGHAM, R.E., HAYNES, A.C., CARR, S.A., ANNAN, R.S., MCNULTY, D.E., LIU, W.S., TERRETT, J.A., ELSHOURBAGY, N.A., BERGSMA, D.J. & YANAGISAWA, M. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92, 573585.
  • SCAMMELL, T.E. & SAPER, C.B. (2005). Orexin, drugs and motivated behaviors. Nat. Neurosci., 8, 12861288.
  • SHAHAM, Y., SHALEV, U., LU, L., DE WIT, H. & STEWART, J. (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berlin), 168, 320.
  • THIELE, T.E., KOH, M.T. & PEDRAZZINI, T. (2002a). Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci., 22, RC208.
  • THIELE, T.E., KOH, M.T. & PEDRAZZINI, T. (2002b). Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci., 22, RC208.
  • THIELE, T.E., MARSH, D.J., STE MARIE, L., BERNSTEIN, I.L. & PALMITER, R.D. (1998). Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature, 396, 366369.
  • THIELE, T.E., MIURA, G.I., MARSH, D.J., BERNSTEIN, I.L. & PALMITER, R.D. (2000). Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacol. Biochem. Behav., 67, 683691.
  • THORSELL, A., RIMONDINI, R. & HEILIG, M. (2002). Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci. Lett., 332, 14.
  • VALDEZ, G.R. & KOOB, G.F. (2004). Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol. Biochem. Behav., 79, 671689.
  • VITTOZ, N.M. & BERRIDGE, C.W. (2006). Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology, 31, 384395.
  • VOLPICELLI, J.R., ALTERMAN, A.I., HAYASHIDA, M. & O'BRIEN, C.P. (1992). Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry, 49, 876880.
  • WINSKY-SOMMERER, R., BOUTREL, B. & DE LECEA, L. (2005). Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol. Neurobiol., 32, 285294.
  • WINSKY-SOMMERER, R., YAMANAKA, A., DIANO, S., BOROK, E., ROBERTS, A.J., SAKURAI, T., KILDUFF, T.S., HORVATH, T.L. & DE LECEA, L. (2004). Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci., 24, 1143911448.
  • World Health Organization (2001). Global Status Report on Alcohol. Geneva: World Health Organization.